24 April 2025

Paediatric oncology TGA

TGA tick for brain cancer drug

10 April 2025

Breast cancer TGA

Ribociclib welcomed in by TGA

27 March 2025

Technology TGA

TGA and international partners prioritise joint product reviews

27 February 2025

Pharmaceuticals TGA

TGA gives tislelizumab the thumbs up

22 August 2024

Allergies FDA TGA

Needle-free adrenaline wins FDA green light

29 November 2023

Immunotherapy TGA

CAR T cell therapy under investigation by FDA

2 November 2023

Cancer TGA

Australian early-stage lung cancer study lauded in Madrid

6 September 2023

TGA TheHill

TGA’s plan to tackle drug shortage

6 September 2023

Political Technology TGA

Make it here or rely forever on OS supply chains, say device experts

12 July 2023

TGA

Peak health bodies unite to fight drug discontinuation

17 May 2023

Drugs TGA

The legacy of John Skerritt

19 April 2023

TGA

Dual drug labelling on the way out

5 October 2022

PBS Shortages TGA

Cancer drugs: PBS listings and shortages

24 August 2022

COVID-19 TGA

TGA paves the way for third covid antiviral

23 March 2022

Breast cancer Clinical research TGA

“Impressive” results in breast cancer drug trial

23 March 2022

Clinical Drugs Medicolegal Political Public Health TGA

Drug approvals ‘rushed, based on limited data’

9 March 2022

COVID-19 prevention therapy TGA

Access concerns for ‘game-changing’ covid therapy